Book a meeting
DO-BO

Are We Ready for a Cultural Shift Toward AI in Pharma, Elizabeth Shanahan?

In this brand new episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Elizabeth Shanahan, AI Strategy Lead at Sanofi, for a refreshingly honest conversation on the real-world implementation of artificial intelligence in pricing, evidence generation, and HTA processes.

From streamlining evidence generation to enhancing pricing strategies and dossier creation, they explore how AI tools are driving efficiency and strategic thinking. Learn how cultural change, human-in-the-loop systems, and transparency with payers are key to success in the digital health era. Whether you’re exploring AI for the first time or scaling adoption across teams, this episode offers strategic insight, hard-won lessons, and a clear-eyed look at the future of pharma.

Related

Why Should Pharma and MedTech Innovators Look at New Zealand, Julius Ohrnberger?

By

Stefan Walzer

Tune in to this new episode of MAP to explore New Zealand’s unique healthcare and reimbursement landscape with Dr. Stefan Walzer and health economist Dr. Julius Ohnberger. Learn how PHARMAC combines HTA and payer roles, why equity and Māori health outcomes are central to market access and what global pharma can gain from launching in […]

What Can Europe and the U.S. Learn from Each Other on Market Access, Anne Loos?

By

Stefan Walzer

Tune in to this new episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer is joined by Anne Loos from Wickenstones, to explore the evolving landscape of U.S. market access and reimbursement. The U.S. reimbursement landscape is changing — driven by AI, global influences with the European JCA and political programs such as […]

Will AI and Living Reviews Define the Next Era of Health Policy, Anna Forsythe?

By

Stefan Walzer

Join this episode of MAP – The Market Access Podcast as Dr. Stefan Walzer sits down with Anna Forsythe, founder of OncoScope-AI, to explore how Living Systematic Literature Reviews (Living SLRs) are redefining evidence generation in oncology and beyond – highlighting the power of real-time updates, advanced automation, and the essential role of human insight. […]